Skip to search formSkip to main contentSkip to account menu

Haemophilus influenzae type b polysaccharide vaccine

Known as: HIB-vaccine, hib vaccine, Hib, unspecified formulation 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Bacterial CapsulesHaemophilus Vaccines
Haemophilus influenzae type b

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.
2011
2011
Immunogenicity and safety of fully liquid DTaP₅-IPV-Hib compared with DTaP₃-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months…
2009
2009
Safety and Immunogenicity of a Pentavalent Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in US Infants and Toddlers and Persistence of Antibodies Before a Preschool…
OBJECTIVE. Our goal was to compare the safety and immunogenicity of a combination vaccine (DTaP5-IPV-Hib; Pentacel) with that of… 
2007
2007
Immunogenicity of a Fourth Dose of Haemophilus influenzae Type b (Hib) Conjugate Vaccine and Antibody Persistence in Young Children from the United Kingdom Who Were Primed with Acellular or Whole…
ABSTRACT In response to the rising incidence of Haemophilus influenzae type b (Hib) disease in the United Kingdom, a national… 
Highly Cited
2006
Highly Cited
2006
Haemophilus influenzae Type b Reemergence after Combination Immunization
Combination vaccines may suppress Hib antibody concentration and avidity. 
2000
2000
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Reported are the effects of elevated levels of anti-tetanus antibodies on the safety and immune response to a Haemophilus… 
Highly Cited
1990
Highly Cited
1990
Variability in the Functional Activity of Vaccine-Induced Antibody to Haemophilus influenzae Type b
ABSTRACT: Sera from 3 of 30 adults vaccinated with Haemophilus influenzae type b polysaccharide vaccine (Hib PS) had poor… 
1989
1989
Subcutaneous versus intramuscular administration of Haemophilus influenzae type b vaccine
FOUR HUNDRED ninety eight children of 15 months to 5 years of age were immunized with 0.5 ml of b-CAPSA™ I Haemophilus influenzae… 
1989
1989
Side-effects and immunogenicity of Haemophilus influenzae type B polysaccharide vaccine in a multiethnic pediatric population.
Side-effects and immunogenicity of the Haemophilus influenzae type B polysaccharide vaccine (Hbpv) were reported following… 
1987
1987
Cloning and expression in Escherichia coli of the gene encoding the heat-modifiable major outer membrane protein of Haemophilus influenzae type b
One major outer membrane protein (P1) of Haemophilus influenzae type b (Hib), with an apparent molecular weight of 34,000 (34K… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)